Rydapt and Tylenol drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Rydapt (midostaurin) and Tylenol (acetaminophen). Common drug interactions include hyperbilirubinaemia among females and acute megakaryocytic leukaemia among males.
The phase IV clinical study analyzes what interactions people have when they take Rydapt and Tylenol. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.
What is Rydapt?
Rydapt has active ingredients of midostaurin. eHealthMe is studying from 2,005 Rydapt users. Check the latest studies of Rydapt.
What is Tylenol?
Tylenol has active ingredients of acetaminophen. It is often used in pain. eHealthMe is studying from 222,309 Tylenol users. Check the latest studies of Tylenol.
19 people who take Rydapt and Tylenol together, and have interactions are studied.

What are the common drug interactions of Rydapt and Tylenol, by gender? *:
female:
- Hyperbilirubinaemia (excess of bilirubin in the blood)
- Leukaemic retinopathy (presence of a yellow-orange fundus of eye due to blood cancer)
- Thrombocytopenia (decrease of platelets in blood)
- Abdominal discomfort
- Antinuclear antibody positive
- Colitis (inflammation of colon)
- Diarrhoea
- Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
- Dyspnoea (difficult or laboured respiration)
- Generalised oedema (swelling all over the body)
male:
- Acute megakaryocytic leukaemia (bone marrow cancer)
- Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
- White blood cell count increased
- Abdominal pain upper
- Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
- Diarrhoea
- Fatigue (feeling of tiredness)
- Gallbladder disorder
- Haemorrhagic stroke (stroke caused by the rupture of a blood vessel in the brain)
- Cholecystitis infective (infection of gallbladder capable to infect other organs)
What are the common drug interactions of Rydapt and Tylenol, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Hyperbilirubinaemia (excess of bilirubin in the blood)
- Abdominal discomfort
- Antinuclear antibody positive
- Colitis (inflammation of colon)
- Diarrhoea
- Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
- Dyspnoea (difficult or laboured respiration)
- Generalised oedema (swelling all over the body)
- Oliguria (not enough urine)
- Thrombocytopenia (decrease of platelets in blood)
50-59:
- Constipation
- Contusion (a type of hematoma of tissue in which capillaries)
- Cough
- Dizziness
- Fatigue (feeling of tiredness)
- Hospitalisation
- Nausea (feeling of having an urge to vomit)
- Neutropenia (an abnormally low number of neutrophils)
- Pneumonia
- Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
60+:
- Transaminases increased
- White blood cell count increased
- Abdominal pain upper
- Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
- Diarrhoea
- Fatigue (feeling of tiredness)
- Gallbladder disorder
- Haemorrhagic stroke (stroke caused by the rupture of a blood vessel in the brain)
What are the existing conditions these people have? *
- Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 13 people, 68.42%
- High Blood Pressure: 9 people, 47.37%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 42.11%
- Nausea (feeling of having an urge to vomit): 7 people, 36.84%
- Constipation: 5 people, 26.32%
- Lower Gastrointestinal Haemorrhage (bleeding in the large intestine, rectum, or anus is called lower gi bleeding): 4 people, 21.05%
- Oropharyngeal Pain: 4 people, 21.05%
- Leukocytosis (increased white blood cells): 4 people, 21.05%
- Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 4 people, 21.05%
- Diarrhea: 4 people, 21.05%
* Approximation only. Some reports may have incomplete information.
Do you take Rydapt and Tylenol?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Rydapt and Tylenol:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Rydapt:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Tylenol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Rydapt and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Tylenol and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on midostaurin and acetaminophen (the active ingredients of Rydapt and Tylenol, respectively), and Rydapt and Tylenol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Myrbetriq cause Therapeutic Response Unexpected? - 4 seconds ago
- Could Zoloft cause Epilepsy? - 6 seconds ago
- Could Vyvanse cause Crohn'S Disease Aggravated? - 11 seconds ago
- Could Terbinafine Hydrochloride cause Head Injury? - 11 seconds ago
- Drug interactions of Epclusa and Dulcolax - 14 seconds ago
- Drug interactions of Naratriptan and Ativan - 17 seconds ago
- Could Haldol cause Crepitations? - 18 seconds ago
- Could Depakene cause Blood Sodium Decreased? - 19 seconds ago
- Could Multaq cause Pericardial Effusion? - 26 seconds ago
- Could Diphenhydramine Hydrochloride cause Viral Infection? - 26 seconds ago